CYP4A22-AS1 is highly expressed in lung adenocarcinoma, gastric cancer, and colorectal cancer, associated with poor patient prognosis, and promotes the proliferation and metastasis of lung adenocarcinoma [39,40,41]. Here, CYP4A22 is linked to colorectal cancer.